摘要
目的:探讨早期服用复方嗜酸乳杆菌片预防足月健康新生儿高胆红素血症的必要性。方法:随机选取2014年1-12月永州市中心医院产科出生的足月健康新生儿328例,采用双盲法将其分为观察组(n=168)和对照组(n=160)。观察组给予出生后新生儿口服复方嗜酸乳杆菌片,对照组不予补充任何益生菌,比较两组的血清总胆红素水平和高胆红素血症发生情况。结果:干预前,两组新生儿血清总胆红素水平比较,差异无统计学意义(P>0.05);干预后,两组比较差异有统计学意义(P<0.05)。观察组发生高胆红素血症21例,对照组为52例,两组比较差异有统计学意义(P<0.05)。结论:复方嗜酸乳杆菌片对预防足月健康新生儿高胆红素血症效果明显。
Objective： To investigate the necessity of prevention of neonatal hyperbilirubinemia in the early administration of Compound Eosinophil- Lactobacillus Tablets.Method： 328 term healthy newborn infants born in the Central Hospital of Yongzhou city from Jannuary 2014 to December 2014 were randomly divided into the observation group（n=168） and the control group（n=160） by double blind method.The observation group was given oral Compound Eosinophil-Lactobacillus Tablets after birth, the control group not to add any probiotics, the serum total bilirubin level and the incidence of hyperbilirubinemia of the two groups were compared.Result： Before the intervention, there was no significant difference between the two groups in the level of total bilirubin（P〉0.05）, after the intervention, the difference between the two groups was statistically significant（P〈0.05）.The observation group of 21 cases of hyperbilirubinemia, 52 patients in the control group, there was significant difference between two groups（P〈0.05）.Conclusion： Compound Eosinophil-Lactobacillus Tablets is on the prevention of neonatal hyperbilirubinemia.
出处
《中外医学研究》
2016年第19期15-16,共2页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
复方嗜酸乳杆菌片
健康足月儿
预防
高胆红素血症
Compound Eosinophil-Lactobacillus Tablets
Healthy full-term infants
Prevention
Hyperbilirubinemia
